• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Route of Administration
o Market segments
o Comparison by Route of Administration
o Enteral nutrition – Market size and forecast 2019-2024
o Parenteral nutrition – Market size and forecast 2019-2024
o Market opportunity by Route of Administration
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o 8.1 Volume driver – Demand led growth
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o B. Braun Melsungen AG
o Baxter International Inc.
o Fresenius SE & Co. KGaA
o GlaxoSmithKline Plc
o Lonza Group Ltd.
o Nestle SA
o Pfizer Inc.
o Reckitt Benckiser Group Plc
o Sanofi
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Other1 – Market share 2019-2024 (%)
• 22: Comparison by Other1
• 23: Enteral nutrition – Market size and forecast 2019-2024 ($ million)
• 24: Enteral nutrition – Year-over-year growth 2019-2024 (%)
• 25: Parenteral nutrition – Market size and forecast 2019-2024 ($ million)
• 26: Parenteral nutrition – Year-over-year growth 2019-2024 (%)
• 27: Market opportunity by Other1
• 28: Customer landscape
• 29: Market share by geography 2019-2024 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2019-2024 ($ million)
• 32: North America – Year-over-year growth 2019-2024 (%)
• 33: APAC – Market size and forecast 2019-2024 ($ million)
• 34: APAC – Year-over-year growth 2019-2024 (%)
• 35: Europe – Market size and forecast 2019-2024 ($ million)
• 36: Europe – Year-over-year growth 2019-2024 (%)
• 37: ROW – Market size and forecast 2019-2024 ($ million)
• 38: ROW – Year-over-year growth 2019-2024 (%)
• 39: Key leading countries
• 40: Market opportunity by geography ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Abbott Laboratories – Overview
• 48: Abbott Laboratories – Business segments
• 49: Abbott Laboratories – Key offerings
• 50: Abbott Laboratories – Key customers
• 51: Abbott Laboratories – Segment focus
• 52: B. Braun Melsungen AG – Overview
• 53: B. Braun Melsungen AG – Business segments
• 54: B. Braun Melsungen AG – Key offerings
• 55: B. Braun Melsungen AG – Key customers
• 56: B. Braun Melsungen AG – Segment focus
• 57: Baxter International Inc. – Overview
• 58: Baxter International Inc. – Business segments
• 59: Baxter International Inc. – Key offerings
• 60: Baxter International Inc. – Key customers
• 61: Baxter International Inc. – Segment focus
• 62: Fresenius SE & Co. KGaA – Overview
• 63: Fresenius SE & Co. KGaA – Business segments
• 64: Fresenius SE & Co. KGaA – Key offerings
• 65: Fresenius SE & Co. KGaA – Key customers
• 66: Fresenius SE & Co. KGaA – Segment focus
• 67: GlaxoSmithKline Plc – Overview
• 68: GlaxoSmithKline Plc – Business segments
• 69: GlaxoSmithKline Plc – Key offerings
• 70: GlaxoSmithKline Plc – Key customers
• 71: GlaxoSmithKline Plc – Segment focus
• 72: Lonza Group Ltd. – Overview
• 73: Lonza Group Ltd. – Business segments
• 74: Lonza Group Ltd. – Key offerings
• 75: Lonza Group Ltd. – Key customers
• 76: Lonza Group Ltd. – Segment focus
• 77: Nestle SA – Overview
• 78: Nestle SA – Business segments
• 79: Nestle SA – Key offerings
• 80: Nestle SA – Key customers
• 81: Nestle SA – Segment focus
• 82: Pfizer Inc. – Overview
• 83: Pfizer Inc. – Business segments
• 84: Pfizer Inc. – Key offerings
• 85: Pfizer Inc. – Key customers
• 86: Pfizer Inc. – Segment focus
• 87: Reckitt Benckiser Group Plc – Overview
• 88: Reckitt Benckiser Group Plc – Business segments
• 89: Reckitt Benckiser Group Plc – Key offerings
• 90: Reckitt Benckiser Group Plc – Key customers
• 91: Reckitt Benckiser Group Plc – Segment focus
• 92: Sanofi – Overview
• 93: Sanofi – Business segments
• 94: Sanofi – Key offerings
• 95: Sanofi – Key customers
• 96: Sanofi – Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations
【掲載企業】
Abbott Laboratories, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE & Co. KGaA, GlaxoSmithKline Plc, Lonza Group Ltd., Nestle SA, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi